MedPharm Ltd, a world-leading contract developer of topical and transdermal pharmaceutical products, is opening a new location in Raleigh-Durham, North Carolina that will expand its CDMO services in topical and transdermal delivery.
Doubling its existing footprint, the facility will support process development, clinical and small-scale commercial manufacturing for semi-solid and liquid pharmaceutical products. This new site, located within a few miles of MedPharm’s current Center of Excellence for topical and transdermal development, gives MedPharm’s clients the opportunity to manufacture clinical batches and commercial-scale products in the US.
“MedPharm’s investment in this facility is a clear demonstration of our continued commitment to a global vision by expanding client services downstream into commercial manufacturing’ stated Eugene Ciolfi, MedPharm’s President and CEO. “MedPharm’s newest facility is an extension of our development services and will also support our client base with their clinical and commercial pipeline needs for topical and transdermal products globally.”
The facility is designed to meet all FDA, EMA and GMP requirements with state-of-the art design, operational support systems, technology and resource management.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!